Food allergy biotech gets $50M loan; Sean Ianchulev’s medical device company raises a $23M Series B
Alladapt Immunotherapeutics put out word on Tuesday that it has entered into a term loan agreement with Hercules Capital for up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
